Antioxidant therapies have been shown to reduce the oxidative stress, reduce susceptibility of low-density lipoprotein (LDL) to oxidation, inhibit secretion of pro-inflammatory cytokines [37], improve insulin signaling in vitro [38], and improve glycemic control in individuals with type 2 diabetes [39,40,41]. This evidence concerns the gene INS and type 2 diabetes mellitus.